若羽臣（003010）公告，控股股东王玉质押140万股，占其所持股份的2.92%，占公司总股本的0.85%。 质押起始日为2025年4月21日，质权人为广发证券股份有限公司，质押用途为个人资金需求。质押前王 玉未持有公司股份，质押后质押股份数量为140万股，占其所持股份的2.92%，占公司总股本的0.85%。 ...

Core Insights - The collaboration between RYTHM (若羽臣) and Aofei Data (奥飞数据) aims to enhance RYTHM's brand management capabilities through localized AI deployment, ensuring efficient and healthy development of its self-developed systems and full-link brand management business [1][3]. Group 1: Strategic Collaboration - Aofei Data will provide RYTHM with secure, stable, and efficient computing power support, driving innovation in RYTHM's brand business through comprehensive digital transformation [1][3]. - The partnership will enable RYTHM to integrate industry-level data assets with core business data assets, facilitating organic collaboration and value release of internal and external data resources [3][5]. Group 2: AI Deployment and Optimization - RYTHM plans to leverage Aofei Data's stable technical services to implement AI projects with a focus on data security, customizing AI models to meet diverse business scenarios [3][8]. - The company will build a group intelligence platform based on high-performance computing power to address multi-scenario operational needs, enhancing business efficiency and decision-making accuracy [7][8]. Group 3: Brand Strategy and Industry Leadership - RYTHM is committed to high-quality business development through digital empowerment, utilizing AI and big data for precise decision-making and operational advancement [8][9]. - The company has integrated advanced models like DeepSeek R1 and OpenAI GPT-4 to create a comprehensive digital decision-making model, optimizing product development, operational decisions, and supply chain management [8][9].

Group 1 - The A-share cross-border e-commerce sector continues to show strong momentum, with Jiuyi Co., Ltd. achieving a 20% limit-up for two consecutive trading days [1] - Xunxing Co., Ltd., Jinjiang Shipping, and Huamao Logistics also reached the daily limit, indicating robust market interest [1] - Other companies such as Suhao Hongye, Ruibeika, Qingdao Jinwang, Ruoyuchen, and Lege Co., Ltd. experienced significant gains, reflecting a broader positive trend in the sector [1]

证券代码：003010 证券简称：若羽臣 公告编号：2025-027 广州若羽臣科技股份有限公司 关于注销回购股份减少注册资本暨通知债权人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 1、申报时间：自 2025 年 4 月 15 日至 2025 年 5 月 29 日（工作日的 9:30-12:00； 14:00-18:00，双休日及法定节假日除外） 2、申报材料送达地点：广东省广州市海珠区鼎新路 8 号欢聚大厦 38 楼 联系人：证券部 联系电话：020-22198215 联系邮箱：ryczjsw@gzruoyuchen.com 3、申报所需材料 （1）可证明债权债务关系存在的合同、协议及其他凭证； （2）债权人为法人的，需同时提供法人营业执照副本、法定代表人身份证明 文件； 广州若羽臣科技股份有限公司（以下简称"公司"）分别于 2025 年 3 月 28 日、2025 年 4 月 14 日召开第四届董事会第六次会议、2025 年第二次临时股东大 会，审议通过了《关于变更回购股份用途并注销的议案》，同意对回购专用证券 账户中的 2024 年度第三期及 ...

关于广州若羽臣科技股份有限公司 2025 年第二次临时股东大会的 法律意见书 致：广州若羽臣科技股份有限公司 北京市中伦（广州）律师事务所（以下简称"本所"）受广州若羽臣科技股份 有限公司（以下简称"公司"）委托，指派本所律师邵芳、周昊臻（以下简称"本 所律师"）出席公司 2025 年第二次临时股东大会（以下简称"本次股东大会"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公 司股东大会规则》等有关法律、法规、规范性文件及《广州若羽臣科技股份有限公 司章程》（以下简称"《公司章程》"）的规定，对公司本次股东大会进行见证并 出具法律意见。 广东省广州市天河区珠江新城华夏路 10 号富力中心 23 楼整层及 31 楼 01、04 单元 邮编：510623 23/F, Units 01 & 04 of 31/F, R&F Center, 10 Huaxia Road, Zhujiang New Town, Tianhe District Guangzhou, Guangdong 510623, P. R. China 电话/Tel : +86 20 2826 1688 传真/Fax : ...

证券代码：003010 证券简称：若羽臣 公告编号：2025-026 广州若羽臣科技股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 （1）现场会议：2025 年 4 月 14 日（周一）14:30 （2）网络投票：2025 年 4 月 14 日，其中通过深圳证券交易所交易系统进行网 络投票的具体时间为 2025 年 4 月 14 日 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）投票的具体 时间为：2025 年 4 月 14 日 9:15-15:00 期间的任意时间。 2、现场会议召开地点：广东省广州市海珠区鼎新路 8 号欢聚大厦 38 楼会议室 3、会议召集人：广州若羽臣科技股份有限公司董事会 4、投票方式 ：本次会议采取现场投票与网络投票相结合的方式召开。本次股 东大会通过深圳证券交易所交易 ...

Investment Rating - The report maintains a "Buy" rating for the cosmetics and medical beauty industry, highlighting the potential for domestic brands to gain market share and improve competitive dynamics [4]. Core Insights - The domestic beauty market is expected to see an optimization in competitive dynamics, driven by a rise in domestic consumption and a retreat of international brands due to increasing geopolitical uncertainties [9][10]. - The cosmetics and medical beauty sector outperformed the market during the period from April 3 to April 11, 2025, with the Shenwan Beauty Care Index declining by 2.5%, which is better than the Shenwan A Index's decline of 1.9 percentage points [5][6]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector showed resilience, with key indices performing better than the overall market, indicating a positive trend for domestic brands [5][6]. - The report notes that the retail sales growth for cosmetics in January and February 2025 was 4.4%, outperforming the overall retail sales growth of 4.0% [23]. Market Trends - According to Euromonitor data, the market for domestic skincare and makeup brands is on the rise, with significant improvements in market share for brands like Proya and Natural Hall, which have entered the top ten in market share [9][35]. - The report anticipates that domestic brands will continue to benefit from the trend of rising domestic consumption, especially as international brands face challenges [10][35]. Company Performance Forecasts - For Q1 2025, several companies are expected to report positive growth: - Up Beauty Co. is projected to see a revenue and net profit increase of 10% year-on-year [11]. - Marubi is expected to achieve a revenue increase of 40% and a net profit increase of 35% [11]. - Proya is forecasted to have a revenue increase of 8% and a net profit increase of 10% [11]. - The report highlights that companies like Giant Biological and Mao Geping are also expected to see significant growth, with revenue and net profit both projected to increase by 40% and 25% respectively [11]. Investment Recommendations - The report recommends focusing on companies with strong brand matrices and high growth potential, such as Up Beauty Co., Proya, and Marubi, which are well-positioned to leverage the e-commerce boom [14]. - It also suggests keeping an eye on companies like Shanghai Jahwa and Betaini, which are expected to perform well in the upcoming quarters [14]. Industry Dynamics - The report discusses the entry of four prominent researchers into Proya, indicating a strong focus on technological innovation and talent development within the company [26]. - The competitive landscape in the medical beauty sector is evolving, with new products and innovations expected to drive growth and market share for companies like Jinbo Biological and Huaxi Biological [29][30].

Group 1 - The stock price of Ruoyuchen (003010) closed at 42.21 yuan on April 1, 2025, down 4.02% with a turnover rate of 3.33% and a trading volume of 40,300 lots, resulting in a transaction amount of 172 million yuan [1] - On April 1, 2025, the net outflow of main funds was 1.4503 million yuan, accounting for 0.84% of the total transaction amount, while retail investors had a net inflow of 2.0391 million yuan, accounting for 1.18% of the total transaction amount [2][4] - The company announced a share repurchase plan on February 19, 2025, with a total repurchase amount not less than 100 million yuan and not exceeding 200 million yuan, with a maximum repurchase price of 42.40 yuan per share [2] Group 2 - As of March 31, 2025, the company had repurchased a total of 292,100 shares, accounting for 0.18% of the total share capital, with a total transaction amount of approximately 9.42 million yuan [3][4] - The highest repurchase price was 34.21 yuan per share, and the lowest was 30.14 yuan per share [3]

广州若羽臣科技股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 证券代码：003010 证券简称：若羽臣 公告编号：2025-025 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号——回购股份》等有关规定，公司在回购期间，应当在每个月的前三个交易 日内披露截至上月末的回购进展情况。现将公司回购股份的进展情况公告如下： 一、回购进展情况 截至2025年3月31日，公司通过股份回购专用证券账户以集中竞价方式已累 计回购公司股份292,100股，占公司目前总股本的0.18%，回购的最高成交价为 34.21元/股，最低成交价为30.14元/股，成交总金额为9,423,747.00元（不含交 易费用）。 本次回购符合相关法律法规的规定和公司回购股份方案的要求。 二、其他说明 公司回购股份的时间、回购股份数量、回购股份价格及集中竞价交易的委托 时段符合《深圳证券交易所上市公司自律监管指引第9号——回购股份》的相关 规定。具体如下： 1、公司未在下列期间内回购股份： （1）自可能对本公司证券及其衍生品种交易价格产生 ...

Group 1 - The company held its sixth meeting of the fourth board of directors on March 28, 2025, to discuss important resolutions [2][5] - The board approved a proposal to change the purpose of share repurchase from "for equity incentives or employee stock ownership plans" to "for cancellation and corresponding reduction of registered capital" [2][11] - The board's decision aims to enhance investor confidence and increase long-term investment value [11][17] Group 2 - The company plans to hold the 2025 second extraordinary general meeting of shareholders on April 14, 2025 [6][21] - The meeting will combine on-site voting and online voting, allowing shareholders to participate remotely [25][26] - The agenda includes the approval of the share repurchase purpose change, which requires a two-thirds majority vote from attending shareholders [30][31] Group 3 - The company has repurchased a total of 5,094,800 shares, which will be canceled, leading to a reduction in registered capital by the same amount [18][19] - The repurchase is expected to enhance earnings per share and improve shareholder returns without adversely affecting the company's financial status [18][19] - The company will continue to follow legal procedures for the share cancellation and capital reduction [19][20]